Dental Diode Laser Device (Laser-Pen)
Guilin Kevin Peter Technology Co., Ltd. · Decision date Sep 18, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 18, 2026 for K261047, a traditional 510(k) submitted by Guilin Kevin Peter Technology Co., Ltd. for the Dental Diode Laser Device (Laser-Pen). The device is listed under the classification name Powered Laser Surgical Instrument, regulation 878.4810, product code GEX, with the regulation medical specialty given as General & Plastic Surgery and the review panel as Dental. The application was received March 31, 2026. SESE denotes clearance to market, not premarket approval.
The FDA document describes the product as a main unit containing a semiconductor laser, battery, cooling system, control system and display system, plus a silicone sleeve and base. Its stated principle of operation is a laser diode emitting invisible infrared radiation delivered to the treatment area through optical means. The record does not state clinical performance data, indications wording, wavelengths, power settings or comparison predicates, so those details remain unknown from this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 18, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261047
- Regulatory pathway
- 510(k) premarket notification
- Product code
- GEX
- Decision code
- SESE
- Decision date
- Sep 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Powered Laser Surgical Instrument.
- Product code
- GEX
- FDA device class
- 2
FDA decision timeline
K261047 received
Application receipt date recorded by FDA.
K261047 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code GEX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Single Use Optical FiberK262886 | Quanta System Spa | 510(k) clearance | Nov 5, 2026 | FDA |
| Borze, Inc. | 510(k) clearance | Oct 30, 2026 | FDA | |
| Risu Medical Technology Co., Ltd. | 510(k) clearance | Oct 27, 2026 | FDA | |
| Sanhe PERFECTLASER Technology Co., Ltd. | 510(k) clearance | Oct 26, 2026 | FDA | |
| Beijing Sea Heart International Science and Technologyco.Ltd | 510(k) clearance | Oct 22, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Guilin Kevin Peter Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Guilin
Sources and methodology
- Original FDA record: K261047
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


